microdosing of tirzepatide Is Safe? vs. Standard Titration Microdosing

Whilst Mounjaro has demonstrated considerable efficacy in clinical trials, patients often have questions about whether the medication might increase their risk of developing specific gastrointestinal conditions, including diverticulitis an inflammatory condition affecting pouches (diverticula) in the colon wall

You might have heard them being referred to as GLP-1 receptor agonists or peptide weight loss drugs, because of how they work (and not to be sticklers, but technically, Mounjaro is a GLP-1/GIP receptor agonist)

Since semaglutide is injected under the skin, meal timing has no impact on drug effectiveness

As the prevalence of obesity continues to rise worldwide, GLP-1 receptor agonists such as Ozempic and Wegovy have gained significant attention from both healthcare professionals and patients seeking clinically proven, non-surgical weight loss solutions